EUVIMEDEUVIMED entdecken
Open Access

The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthma

Graeme P Currie, Tom C Fardon, Daniel Kc Lee

Therapeutics and Clinical Risk Management · 2005

DOI: 10.2147/tcrm.1.2.83.62909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutics and Clinical Risk Management, 2005. Verfasst von Graeme P Currie und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthma is characterized by inflammation and airway hyperresponsiveness, which results in episodic airflow obstruction. It is diagnosed once a compatible clinical history plus objective evidence of diurnal variability in peak expiratory flow or significant reversibility to inhaled bronchodilator is documented. In accordance with current guidelines, measures of airway calibre and symptoms allow patients and clinicians to assess the degree of asthma control and titrate pharmacotherapy. However, these parameters fail to reflect the extent of underlying endobronchial inflammation and airway hyperresponsiveness, which in turn suggests that additional measures of asthma control may be of benefit. This evidence-based review highlights ways by which inflammation and airway hyperresponsiveness can be assessed and how they may provide additional useful information in the diagnosis and management of asthmatic patients.

Zitieren

APA

Currie, G. P., Fardon, T. C., & Lee, D. K. (2005). The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthma. Therapeutics and Clinical Risk Management. https://doi.org/10.2147/tcrm.1.2.83.62909

Vancouver

Currie GP, Fardon TC, Lee DK. The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthma. Therapeutics and Clinical Risk Management. 2005. doi:10.2147/tcrm.1.2.83.62909

BibTeX
@article{Currie2005,
  author = {Currie, Graeme P and Fardon, Tom C and Lee, Daniel Kc},
  title = {The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthma},
  journal = {Therapeutics and Clinical Risk Management},
  year = {2005},
  doi = {10.2147/tcrm.1.2.83.62909}
}
Kostenlos starten →